358 articles
Stay up to date with the latest stock market news, analysis, and market-moving events.
1492 Capital Management initiates $3.5M position in Cabot Corporation despite flat stock performance and declining earnings, betting on cyclical recovery potential.
Target's 3.5% dividend backed by 54 years of increases may offer better value than Conagra's 9.4% yield amid declining revenues and business challenges.
CVS Health stock has declined 3% this year despite record revenue growth and successful integration of pharmacy, insurance, and care services creating unique competitive advantages.
DXP Enterprises shares rose 3.7% to $162.55 following strong quarterly results from industry peer Genuine Parts Company, reflecting positive sentiment across the industrial distribution sector.
Dell Technologies climbed 3.1% after Melius Research and Citigroup raised price targets, citing growing AI server demand and competitive opportunities in the enterprise market.
The VSS ETF offers exposure to 4,950 international small-cap stocks trading at 1.6x book value, providing geographic diversification at a 0.06% expense ratio.
E.l.f. Beauty, Vita Coco, and Dutch Bros demonstrate strong operational performance despite market volatility, each leveraging unique competitive advantages for continued growth.
Biogen stock rose 3.6% following Wells Fargo's upgrade to 'Overweight' with a $250 price target and the company's acquisition of exclusive worldwide rights to drug candidate felzartamab.
Okta shares jumped 4.7% following upgrades from Barclays and Raymond James, with analysts citing the company's positioning in AI security as enterprise identity management becomes a priority.
Gray Television, Encore Capital Group, and Citigroup have posted strong monthly gains, but fundamental analysis reveals potential concerns about debt levels and growth trends.
Analysis reveals two financial companies showing strong growth trajectories while one established player faces performance headwinds amid sector challenges.
Alphabet's 5% stake in SpaceX could be worth $100 billion when the rocket company goes public at a $2 trillion valuation, creating a unique backdoor investment opportunity.
Get the latest stock market news and analysis delivered to your inbox.
No spam, unsubscribe anytime. See our Privacy Policy.
We use cookies to enhance your browsing experience and analyze site traffic. By clicking "Accept", you consent to our use of cookies.